# The GLP-1 Economy: How New Prescriptions Are Reshaping Markets

Page: https://stenobird.com/podcast/the-important-part-investing-with-liz-thomas-4491939/the-glp-1-economy-how-new-prescriptions-are-reshaping-markets
Text version: https://stenobird.com/podcast/the-important-part-investing-with-liz-thomas-4491939/the-glp-1-economy-how-new-prescriptions-are-reshaping-markets.md
Podcast: [The Important Part: Investing with Liz Thomas](https://stenobird.com/podcast/the-important-part-investing-with-liz-thomas-4491939)
Published: 2026-07-01T07:00:00+00:00
Episode link: https://tracking.swap.fm/track/Vjambo9ifGBwbaCTlDBD/traffic.megaphone.fm/SFL8419070241.mp3
Audio file: https://tracking.swap.fm/track/Vjambo9ifGBwbaCTlDBD/traffic.megaphone.fm/SFL8419070241.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-important-part-investing-with-liz-thomas-4491939/episodes/the-glp-1-economy-how-new-prescriptions-are-reshaping-markets
Duration seconds: 2587

## Resource

About one in eight U.S. adults say they take a GLP-1 drug, according to a poll by the Kaiser Family Foundation. And that raises a number of questions for investors. As use of drugs such as Ozempic, Wegovy and Zepbound grows, the effects are moving far beyond healthcare and into the way people eat, shop, and spend. In this episode of The Important Part, Liz Thomas sits down with Caleb Silver, editor-in-chief of Investopedia and Chief Business Editor at People Inc., to examine the rise of the “GLP-1 economy.” Together, they explore how changing consumer behavior could affect food companies, restaurants, apparel, travel, home appliances, telehealth, and the pharmaceutical industry. Liz and Caleb also discuss where new demand may emerge, which established businesses could face pressure, and what investors should watch as the GLP-1 market continues to develop. Can major brands adapt quickly enough, or will a new group of companies be built around this changing consumer? This episode is for informational purposes only and should not be considered investment or medical advice. For more, read Liz’s column every Thursday at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠On The Money⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ by SoFi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and follow Liz on Twitter ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@LizThomasStrat⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Additional resources: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠On The Money⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: Sign up for SoFi's newsletter for intel, insights, and inspo to help you get your money right. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Investing 101 Center⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: At SoFi, we believe investing is for everyone — which is why we’ve created a hub with info for beginners and experts alike. Start exploring to get investment education, advice, resources, and more. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Wealth Investing Guide⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: Information you need to know to make your money…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-important-part-investing-with-liz-thomas-4491939/episodes/the-glp-1-economy-how-new-prescriptions-are-reshaping-markets/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-important-part-investing-with-liz-thomas-4491939/the-glp-1-economy-how-new-prescriptions-are-reshaping-markets.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.